As general counsel, Mr Zachara will lead Cambrex’s legal function, overseeing the traditional legal activities related to commercial transactions, intellectual property, regulatory compliance, environmental, litigation, employment, corporate governance,
Prior to his recent retirement from Bristol-Myers, Dr Smyth led oncology medical affairs in the US, including the US life-cycle development of paclitaxel, carboplatin and ifosfamide. Prior to
In this role, Mr Cuneo is responsible for coordinating Mylan’s global business development and strategic efforts in close alignment with the company’s executive leadership team. Mr Cuneo joins
Mr Myslinski has been a Johnson & Johnson executive since 2002 where his responsibilities have included building a new, world-wide evidence based medicine function for the ortho-clinical diagnostics
The terms of the licensing agreement provide for payments to Rosetta, either as milestones or R&D funding, as well as royalty payments on net sales in the US.
India-based Glenmark Pharmaceuticals has reported that its candidate for neuropathic pain, osteoarthritis and other inflammatory pain disorders – GRC 10693, has successfully completed Phase I trials in Europe.
Suven Life Sciences, an Indian drug discovery and development company, has completed its Phase I multiple ascending dose study of SUVN-502 in healthy volunteers. SUVN-502 is reported to
Xoft, a developer of electronic brachytherapy systems, has received a medical device license from the Medical Devices Bureau of Health Canada to sell and market the Axxent electronic
The company reported net sales of $615 million for the three months ended February 28, 2009, an increase of 2%, compared to $603.1 million for the three months
The contract, valued at GBP1.1 million, is for process development and GMP manufacture of specific antibodies. This contract will be delivered by mid-2010. The company also signed a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.